Skip to content

Preventing the Risk of Osteoporotic Fracture in Premenopausal Women by a Spa Residential Physical Activity Program

Preventing the Risk of Osteoporotic Fracture in Premenopausal Women by a Spa Residential Physical Activity Program

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03570008
Acronym
ThermOs
Enrollment
90
Registered
2018-06-26
Start date
2017-03-01
Completion date
2021-03-01
Last updated
2018-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporotic Fracture

Keywords

prevention, bone, physical activity, spa bath, women

Brief summary

Osteoporosis is an increasing public health problem. Involution of bone mass in women is due to a reduction in sensitivity of the bone to the mechanical stress due to the slow-down of the bone turnover after 35 years old. Osteoporosis is a silent disease combining a decrease in bone mass (quantity) and an impaired bone microarchitecture (quality) leading to an increased risk of fracture. Bone microarchitecture is an important element to be taken into account in assessing the bone properties, as demonstrated by numerous ex vivo studies. Bone densitometry only identifies 50% of osteoporotic fractures. The other half of the fractures appears in osteopenic women. The measurement of bone mineral density is too limited to assess risk of fracture. Bone microarchitecture can be assessed through a peripheral quantitative computed tomography scan (computed tomography peripherical - pQCT). The microarchitecture data allow the calculation of bone strength index (BSI) and stress strength index (SSI) highly predictive of fracture risk. These qualitative determinants of bone fragility are the most relevant to evaluate effect of physical activity over a short period compared with bone mineral content and density, which requires several months of constraints. Biochemical markers of bone turnover, specifically those of bone resorption, are predictive of the risk of osteoporotic fracture. Physical activity can reduce the risk of fracture up to 20-35% via direct effects on bone strength, at any age. However, response of bone varies with modalities of exercise. Repeated exercise produces greater bone adaptations than a single bout. Moreover, it has been well demonstrated since 1970 that bone responds to a dynamic stimulation, but not a static stimulation, with a dose response relationship. It has been confirmed in premenopausal women. The effect of physical activity on microarchitectural bone parameters (porosity and density of cortical and trabecular) has not been investigated in primary prevention. This original study would highlight the effect of short-term specific physical activity on the prevention of bone fragility (qualitative) observed with age in premenopausal women. The main hypothesis is that a spa residential program including physical activity will have greater benefits on bone cortical porosity than a spa residential program alone or physical activity alone, in premenopausal women.

Detailed description

The ThermOs protocol was designed to provide a better understanding of the effect of physical activity on microarchitectural bone parameters (porosity and density of cortical and trabecular), in prevention of bone fragility among premenopausal women. In the present protocol, parameters are measured on four occasions (baseline, 10 days, at 6 months and at 12 months). Statistical analysis will be performed using Stata software (version 13; Stata-Corp, College Station, Tex., USA). All statistical tests will be two-sided and p\<0.05 will be considered significant. After testing for normal distribution (Shapiro-Wilk test), data will be treated either by parametric or non-parametric analyses according to statistical assumptions. Inter-groups comparisons will systematically be performed 1) without adjustment and 2) adjusting on factors liable to be biased between groups. Analysis will be performed using anova or Kruskal-Wallis (KW) tests. When appropriate (p\<0.05), a post-hoc test for multiple comparisons (Tukey-Kramer after anova and Dunn post KW) will be used. Linear regression (with logarithmic transformation if necessary) considering an adjustment on covariates fixed according to epidemiological relevance and observance to physical activity will complete the analysis. Relations between quantitative outcomes will be analyzed using correlation coefficients (Pearson or Spearman) and compared with Chi-squared or Fischer test. Longitudinal data will be treated using mixt-model analyses in order to treat fixed effects group, time and group x time interaction taking into account between and within participant variability.

Interventions

BEHAVIORAL9 days spa residential program

After the inclusion visit, the participants will be involved in a short-term spa residential program of 9 days (Sp). The will be randomized into 3 groups of 30 participants: * Sp-Ex: spa residential program including physical activity * Sp-alone: spa residential program alone * Ex-alone: physical activity alone After the spa residential program, participants will undergo a one-year at-home follow-up. The participants will be required to complete the same program by themselves. A journal and an accelerometer-pedometer watch will record the weekly physical activity performed. Monitoring will be further monthly assessed by a health-care professional from the spa resorts.

BEHAVIORAL3 sessions of 10 minutes per day of physical exercise

After the inclusion visit, the participants will be involved in a short-term spa residential program of 9 days (Sp). The will be randomized into 3 groups of 30 participants: * Sp-Ex: spa residential program including physical activity * Sp-alone: spa residential program alone * Ex-alone: physical activity alone After the spa residential program, participants will undergo a one-year at-home follow-up. The participants will be required to complete the same program by themselves. A journal and an accelerometer-pedometer watch will record the weekly physical activity performed. Monitoring will be further monthly assessed by a health-care professional from the spa resorts.

Sponsors

Regional Council of Auvergne-Rhône-Alpes
CollaboratorOTHER
European Regional Development Fund
CollaboratorOTHER
Spa resort of Chaudes Aigues, 27 avenue Georges Pompidou, BP21, 15110 Chaudes Aigues, France
CollaboratorUNKNOWN
Spa resort of Bourbon-Lancy, place d'Aligre 71140 Bourbon-Lancy, France
CollaboratorUNKNOWN
Innovatherm
CollaboratorINDUSTRY
Université d'Auvergne
CollaboratorOTHER
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

No masking

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Women with regular cycles * 40-50 years old * Sedentary lifestyle * stable body weight over the previous 6 months * Normal weighted (BMI\<30) * written informed consent. * Affiliated to French health care system (for France)

Exclusion criteria

* Menopausal women * Regular physical activity \> 4 hours / week of moderate or high intensities * Participant refusal to participate * Hepatic, renal, or psychiatric diseases, nor cardiovascular or endocrine diseases (thyroid diseases will be included) * HIV infection * Use of medications altering body weight, corticosteroids, Nonsteroidal anti-inflammatory drugs * Use of medications influencing bone parameters such as bisphosphonate, other osteoporotic treatment therapy, or chemotherapy * Regular alcohol consumption (\>20g of alcohol per day) * Restricted diet over the previous 6 months * Deficit or supplementation in vitamin D * Protected persons are not excluded

Design outcomes

Primary

MeasureTime frameDescription
Variation of bone cortical porosity in premenopausal women after the interventional phase.at BaselineTo evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
Variation of bone cortical porosity in premenopausal womenafter 10 daysTo evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.

Secondary

MeasureTime frameDescription
bone fracture riskat Baseline, after 10 days, after 6 months, after 12 monthsquestionnaire (FRAX - Fracture Risk Assessment Tool, bone fracture risks ; after registering results from DXA and personal details the computer calculates the fracture risks based on an algorithm)
General Healthat Baseline, after 10 days, after 6 months, after 12 monthsGeneral Health will be measured using the General Health Questionnaire, (there is no score, just informative health information)
Greater short-term benefits on health factors with the Sp-Ex program than with Sp-alone or Ex-alone (Bone health will be obtained from the combination of 5 measures).at Baseline, after 10 days, after 6 months, after 12 monthsEvaluate the effectiveness of the Sp-Ex program compared with the Sp-alone or Ex-alone on short-term modification of health factors among premenopausal women.
Physical Activityat Baseline, after 10 days, after 6 months, after 12 monthsQuality of life will be measured using the SF-36 (Short Form 36 ; 9 sections questionnaire ; scale range from 0 (bad) to 100(excellent))
Quality of lifeat Baseline, after 10 days, after 6 months, after 12 monthsCalcium intake will be measured using the Fardellonne questionnaire (recommended daily consummation in France: women 900 mg/d; women \>55 years old 1200mg/d)
Calcium intakeat Baseline, after 10 days, after 6 months, after 12 monthsDepression and anxiety will be measured using Hamilton scale (scale range from 0 to 4, if \> 20 high level of anxiety)
Depression and anxietyat Baseline, after 10 days, after 6 months, after 12 monthsDepression and anxiety will be measured using the Hospital anxiety and depression scale (scale range from 0 to 3, with a total score between 0 to 21. Threshold score is 8)
Anxietyat Baseline, after 10 days, after 6 months, after 12 monthsBurn-out will be measured using the Maslach Burn Out Inventory (scale range from 0 to 6, with 0 = never and 6 = almost always)
Burn-outat Baseline, after 10 days, after 6 months, after 12 monthsJob content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
Job contentat Baseline, after 10 days, after 6 months, after 12 monthsJob content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
Body massat Baseline, after 10 days, after 6 months, after 12 monthsBody mass (muscle and fat) will be measured using Impedancemeter
Anthropometryat Baseline, after 10 days, after 6 months, after 12 monthsweight (kg) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
Basic biologyat Baseline, after 10 days, after 6 months, after 12 monthsHbA1c (mmol/mol) will be measured using endocrine assays
electrodermal activityat Baseline, after 10 days, after 6 months, after 12 monthselectrodermal activity (skin conductance) will be measured using Wirst band electrodes
Vitamin Dat Baseline, after 10 days, after 6 months, after 12 monthsVitamin D will be measured using endocrine assays
Leptinat Baseline, after 10 days, after 6 months, after 12 monthsLeptin will be measured using endocrine assays
Pro-inflammatory cytokineat Baseline, after 10 days, after 6 months, after 12 monthsPro-inflammatory cytokine (IL-1β, IL-6, IL-1, TNFα, IFNγ) will be measured using endocrine assays
heart rate variabilityat Baseline, after 10 days, after 6 months, after 12 monthsheart rate variability will be measured using Holter
physical activity behaviourat Baseline, after 10 days, after 6 months, after 12 monthsphysical activity behaviour will be measured using an activity journal (participant will have to write all their daily activity from when they wake up to when they go to bed)

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr0473751195

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026